The estimated Net Worth of Dennis L Winger is at least $29.5 million dollars as of 17 August 2018. Dennis Winger owns over 30,000 units of Vertex Pharmaceuticals stock worth over $27,416,235 and over the last 15 years Dennis sold VRTX stock worth over $2,075,550.
Dennis has made over 8 trades of the Vertex Pharmaceuticals stock since 2012, according to the Form 4 filled with the SEC. Most recently Dennis exercised 30,000 units of VRTX stock worth $427,800 on 17 August 2018.
The largest trade Dennis's ever made was selling 34,250 units of Vertex Pharmaceuticals stock on 13 August 2018 worth over $2,075,550. On average, Dennis trades about 3,620 units every 50 days since 2009. As of 17 August 2018 Dennis still owns at least 57,750 units of Vertex Pharmaceuticals stock.
You can see the complete history of Dennis Winger stock trades at the bottom of the page.
Dennis's mailing address filed with the SEC is 1310, Chesapeake Terrace, Sunnyvale, Santa Clara County, California, 94089, United States.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden et Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: